Kala Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $254 | $0 |
Gross Profit | -67 | -68 | 127 | -63 |
EBITDA | -11,028 | -10,669 | -6,714 | -7,409 |
EBIT | -10,737 | -6,783 | -7,472 | |
Net Income | -11,155 | -8,947 | -8,175 | -8,950 |
Net Change In Cash | 0 | 0 | 254 | 0 |
Free Cash Flow | -7,734 | -8,824 | -4,667 | -4,676 |
Cash | 31,942 | 42,222 | 51,181 | 49,202 |
Basic Shares | 6,513 | 6,345 | 4,694 | 4,627 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,892 | $11,240 |
Gross Profit | -259 | -303 | 1,332 | 7,143 |
EBITDA | -40,983 | -36,082 | -36,696 | -131,957 |
EBIT | -44,294 | -36,385 | -37,556 | -134,225 |
Net Income | -38,511 | -42,199 | -44,822 | -142,605 |
Net Change In Cash | 0 | 0 | 3,892 | 11,240 |
Free Cash Flow | -29,590 | -28,537 | -79,221 | -109,121 |
Cash | 51,181 | 50,895 | 70,495 | 92,136 |
Basic Shares | 5,520 | 2,432 | 1,520 | 1,304 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.71 |
2025-03-31 | -$1.74 |
2024-12-31 | -$1.23 |
2024-09-30 | -$1.93 |
